Reven selects eClinical services provider DSG to accelerate Reven’s RJX as treatment for COVID-19

Reven selects eClinical services provider DSG to accelerate Reven’s RJX as treatment for COVID-19

GOLDEN -- Reven Holdings, Inc. today announced it selected DSG, Inc., a leading global eClinical services provider, for all aspects of clinical trial data management during its upcoming COVID-19... Read More

Wednesday September 30, 2020 Tags: Golden, Reven Holdings, Reven Pharmaceuticals, DSG, Fatih Uckun, Michael Volk, Tony Varano, COVID-19